68.15USD+1.63%Mkt Cap: 2.32B USDP/E: 15.38Last update: 2026-06-01
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap2.32B USD
Enterprise Value2.72B USD
Revenue (TTM)635.89M USD
Gross Profit362.81M USD
Net Income (TTM)190.29M USD
Revenue/Share18.62 USD
Last Price68.15 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees898
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)15.38
P/E (Forward)18.91
PEG—
EV/EBITDA21.73
EV/Revenue4.28
P/S3.65
P/B4.87
EPS (TTM)4.37
EPS (Forward)3.55
52W Range
60.108% of range156.00
52W High156.00 USD
52W Low60.10 USD
Profitability
Gross Margin59.92%
Oper. Margin7.65%
EBITDA Margin19.71%
Profit Margin31.43%
ROE40.22%
ROA17.81%
Growth
Revenue Growth21.20%
Earnings Growth-71.50%
Cash Flow & Leverage
Operating CF192.84M USD
CapEx (TTM)59.25M USD
FCF Margin17.11%
FCF Yield4.68%
Net Debt401.68M USD
Net Debt/EBITDA3.20
Balance Sheet
Debt/Equity1.10
Current Ratio6.74
Quick Ratio6.01
Book Value/Sh13.81 USD
Cash/Share13.36 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)116.78 USD
Target Range75.00 USD – 142.00 USD
# Analysts9
Ownership
Shares Out.34.56M
Float33.45M
Insiders3.40%
Institutions108.82%
Short Interest
Short Ratio4.9d
Short % Float36.91%
Short % Out.23.66%
Shares Short8.18M
Short (prev mo.)7.61M
Technical
SMA 5093.47 (-27.1%)
SMA 200118.41 (-42.4%)
Beta2.06
S&P 52W Chg27.70%
Avg Vol (30d)1.57M
Avg Vol (10d)1.38M
Technical Indicators
RSI (14)31.2
MACD-8.4448
MACD Signal-9.8913
MACD Hist.+1.4465
BB Upper94.67 USD
BB Middle71.96 USD
BB Lower49.26 USD
BB Width63.11%
ATR (14)4.780 USD
Vol Ratio (20d)0.42x